Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSage Group Regulatory News (SGE)

Share Price Information for Sage Group (SGE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,183.00
Bid: 1,181.00
Ask: 1,182.00
Change: 0.00 (0.00%)
Spread: 1.00 (0.085%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 1,183.00
SGE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Disclosure under S. 430(2B) Companies Act 2006

7 Apr 2020 15:00

RNS Number : 0955J
Sage Group PLC
07 April 2020
 

Disclosure under section 430(2B) Companies Act 2006

On 17 January 2020 The Sage Group plc ("Sage") announced that Blair Crump, President and Executive Director, would retire on 31 March 2020. Mr Crump stood down from the Board at the Annual General Meeting on 25 February 2020 and retired from his role as President on 31 March 2020.

The appendix to this announcement sets out information on Mr Crump's departure required to be disclosed pursuant to section 430(2B) of the Companies Act 2006.

Enquiries

The Sage Group plc +44 (0) 191 294 3457

 

James Sandford, Investor Relations

Rebecca Potgieter, Media

 

FTI Consulting +44 (0) 20 3727 1000

 

Charles Palmer

Dwight Burden

 

About Sage

Sage is the global market leader for technology that helps small and medium businesses perform at their best. Sage is trusted by millions of customers worldwide to deliver the best cloud technology and support, with our partners, to manage finances, operations, and people. We believe in doing everything we can to help people be the best they can be, so the combined efforts of 13,000 Sage colleagues working with businesses and communities make a real difference to the world.

Appendix

The following information is provided pursuant to section 430(2B) of the Companies Act 2006. The financial terms below have been agreed with Mr Crump in connection with his announced departure and are in line with Sage's Remuneration Policy which was approved by the shareholders at the 2019 AGM.

The following arrangements will apply in respect of Mr Crump's departure:

· Mr Crump's termination date was 31 March 2020. Following this date, Sage Software Inc. (the "Company") will continue to pay Mr Crump a sum equal to his monthly base salary for a period of six months. These payments will be made in biweekly instalments and will be subject to deductions for mitigation.

· Provided that Mr Crump meets certain eligibility requirements under US law, the Company will pay Mr Crump a lump sum equal to six months of Company contributions under the Company's health plan.

· The Company will pay the professional adviser costs incurred by Mr Crump in connection with statutory tax filings for the tax years in which he has tax liabilities on Company-related income. These costs will only be covered by the Company to the extent that they relate to Company-related tax liabilities. Additionally, the Company will continue to tax-equalise that portion of Mr Crump's Company-related remuneration that becomes subject to UK tax for days on which he attended to Company matters from the Company's UK offices.

· The Company will make a contribution of up to a maximum of USD10,000 (plus taxes) towards Mr Crump's legal fees incurred in connection with the arrangements relating to his departure.

Other terms agreed with Mr Crump, which were the subject of careful consideration by the Remuneration Committee, are as follows:

· Mr Crump will remain eligible to receive a bonus in respect of the 2020 financial year, subject to the Remuneration Committee's determination as to the achievement of any applicable financial and personal performance conditions. Any bonus awarded to Mr Crump will be pro-rated by reference to the period of the bonus year which had elapsed by 31 March 2020 and will be paid in cash.

· Mr Crump will be treated as a good leaver in respect of his existing awards under Sage's Performance Share Plan (PSP) and Deferred Share Bonus Plan (DSBP). He will be eligible to receive a pro-rated proportion of the PSP awards granted during the 2018 and 2019 financial years that remained unvested as at 31 March 2020. Mr Crump's PSP award granted in December 2019 will lapse given the short period between its grant and his departure. The PSP awards will be based on the number of days that Mr Crump was employed by the Company during the relevant performance period. The DSBP award will not be subject to time pro-rating. The awards will vest on their normal vesting dates subject to the PSP and DSBP plan rules and compliance with certain post-termination covenants. 

Information on the vesting of the PSP and DSBP awards will be disclosed in the relevant directors' remuneration reports following vesting. Any awards which are currently subject to malus and clawback provisions set out in the relevant plan rules and the post-employment shareholding requirement set out in the 2019 Directors' Remuneration Report will continue to be subject to such provisions.

The table below sets out the relevant number of shares under each of Mr Crump's PSP and DSBP awards, along with date of grant and date of vesting. In the case of the PSP, vesting (and therefore future value) is subject to the achievement of applicable stretching performance conditions. The DSBP awards relate to deferred bonuses already earned for previous performance years.

Type of award

Grant date

Number of shares under award

Vesting date (release date where different)

PSP award

PSP

07/12/2017

171,814

07/12/2020

PSP

28/02/2019

190,027

04/12/2021 (04/12/2023)

DSBP awards

DSBP

02/12/2019

38,558

02/12/2022

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCIRMJTMTBMBMM
Date   Source Headline
13th Feb 20236:16 pmRNSPublication of Final Terms
9th Feb 20239:32 amRNSDirector/PDMR Shareholding
7th Feb 20239:46 amRNSDirector/PDMR Shareholding
3rd Feb 202312:14 pmRNSDirector Declaration
2nd Feb 20233:31 pmRNSResult of AGM
2nd Feb 20239:57 amRNSDirector Declaration
31st Jan 20233:35 pmRNSSage: Publication of Base Prospectus
31st Jan 20233:00 pmRNSTotal Voting Rights
23rd Jan 20234:58 pmRNSDirector/PDMR Shareholding
19th Jan 20237:00 amRNSTrading Update for the 3 months ended 31 Dec 2022
30th Dec 202211:15 amRNSTotal Voting Rights
15th Dec 202211:21 amRNSDirector/PDMR Shareholding
8th Dec 20225:40 pmRNSDirector/PDMR Shareholding
8th Dec 20227:00 amRNSUpdate on financial reporting
7th Dec 20226:00 pmRNSDirector/PDMR Shareholding
7th Dec 202210:12 amRNSNotice of AGM
6th Dec 20226:13 pmRNSDirector/PDMR Shareholding
6th Dec 20225:23 pmRNSDirector/PDMR Shareholding
6th Dec 202210:25 amRNSBlock listing Interim Review
1st Dec 202211:03 amRNSAnnual Financial Report
30th Nov 20222:00 pmRNSTotal Voting Rights
24th Nov 202210:00 amRNSNon-executive Director Appointment
18th Nov 20229:13 amRNSDirector/PDMR Shareholding
16th Nov 20227:00 amRNSResults for the year ended 30 September 2022
15th Nov 20227:00 amRNSNon-executive Director Appointment
31st Oct 20223:00 pmRNSTotal Voting Rights
30th Sep 202211:45 amRNSTotal Voting Rights
20th Sep 20227:00 amRNSInvestor and Analyst Event
31st Aug 20223:44 pmRNSTotal Voting Rights
30th Aug 20225:10 pmRNSSage completes Lockstep acquisition
24th Aug 20223:37 pmRNSDirector/PDMR Shareholding
18th Aug 202210:19 amRNSDirector/PDMR Shareholding
16th Aug 20227:00 amRNSSage to acquire Lockstep
2nd Aug 20227:00 amRNSTrading update for nine months ended 30 June 2022
29th Jul 20224:04 pmRNSTotal Voting Rights
22nd Jul 20229:02 amRNSDirectorate Change
30th Jun 20224:10 pmRNSTotal Voting Rights
24th Jun 20224:34 pmRNSDirector/PDMR Shareholding
16th Jun 20223:38 pmRNSDirector/PDMR Shareholding
8th Jun 20224:48 pmRNSDirector/PDMR Shareholding
8th Jun 20229:00 amRNSDirector Declaration
7th Jun 20222:53 pmRNSDirector/PDMR Shareholding
6th Jun 20222:00 pmRNSBlock listing Interim Review
31st May 20225:09 pmRNSTotal Voting Rights
25th May 20225:24 pmRNSDirector/PDMR Shareholding
19th May 20225:36 pmRNSDirector/PDMR Shareholding
19th May 20225:20 pmRNSDirector/PDMR Shareholding
13th May 20227:00 amRNSResults for the 6 months to 31 March 22 unaudited
29th Apr 20224:10 pmRNSTotal Voting Rights
31st Mar 20223:45 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.